Slide background
Slide background




EudraBook Compendium of EU pharmaceutical law

ID 6831 | | Visite: 7543 | MedicinalPermalink: https://www.certifico.com/id/6831

EudraBook

EudraBook Compendium of EU pharmaceutical law

2015 marks the 50th anniversary of pharmaceutical legislation in the EU, which began with Directive 65/65 in 1965 in the wake of the Thalidomide disaster.

The EU legal framework for medicinal products for human use guarantees high standards of quality and safety of medicinal products and intends to promote the functioning of the internal market, with measures which encourage innovation and competiveness in Europe. It is based on the principle that medicinal products may be placed on the market only following a marketing authorisation granted by the competent authorities.

A large body of legislation has developed around this principle, with the progressive harmonisation of requirements for the granting of marketing authorisations since the 1960s, implemented across the whole European Economic Area.

Nowadays, medicinal products may be either authorised centrally by the European Commission or nationally by Member States’ competent authorities. The European Medicines Agency, established in 1995, underpins the centralised authorisation procedure and supports coordination between national competent authorities. The Agency is the hub of a European medicines network comprising over 40 national regulatory authorities guaranteeing a constant exchange and flow of information regarding the scientific assessment of medicinal products in the EU.

The EU legal framework is definitely not an area in which the law stands still. Quite the contrary, its history is marked by a constant ambition to improve its functioning or tackling shortcomings in order to guarantee the right balance between early access of patients to new medicines and high standards of quality and safety. Moreover, over the past 50 years science has developed. New technologies and further knowledge about diseases led to the introduction of new concepts or re-shaping of existing medical therapies that were subsequently mirrored in legislation.

The pharmaceutical sector is characterised by an abundance of guidelines intended to help and support the key players in the application of the EU legal framework. Still, the guidance documents would be nothing without the basic legislation on which they build.

To understand the EU legal framework for medicinal products it is important to know the applicable provisions of the legislation itself. This E-Book is intended to support readers in this regard by putting together the most recent versions of the key legal instruments on medicinal products for human use. It provides a useful overview for stakeholders, especially the pharmaceutical industry, regulatory authorities, legal practitioners, but also interested citizens, patients and healthcare professionals.

This E-Book reflects the law as it stands on 1 January 2015

Eudralex Ebook Version 1.3 06/05/2015

DescrizioneLinguaDimensioneDownloads
Scarica questo file (EudraBook Compendium of EU pharmaceutical law 2015.pdf)EudraBook Compendium of EU pharmaceutical law 2015
 
EN1558 kB717

Tags: Medicinal

Ultimi archiviati Chemicals

Giu 24, 2022 48

Regolamento (UE) 2021/2142

Regolamento (UE) 2021/2142 Regolamento (UE) 2021/2142 della Commissione del 3 dicembre 2021 che modifica il regolamento (CE) n. 1881/2006 per quanto riguarda i tenori massimi di alcaloidi oppiacei in alcuni prodotti alimentari. (GU L 433 del 6.12.2021) Collegati[box-note]Regolamento (CE) n.… Leggi tutto
Faster action on groups of harmful chemicals
Giu 17, 2022 76

ECHA - Integrated Regulatory Strategy (IRS) Annual Report 2021

ECHA - Integrated Regulatory Strategy (IRS) Annual Report 2021 Faster action on groups of harmful chemicals - Integrated Regulatory Strategy Annual Report June 2022 Helsinki, 17 giugno 2022 È stato pubblicato il quarto rapporto dell'ECHA nell'ambito della sua strategia di regolamentazione… Leggi tutto
Mag 31, 2022 103

Decreto 11 ottobre 2001

Decreto 11 ottobre 2001 Condizioni per l'utilizzo dei trasformatori contenenti PCB in attesa della decontaminazione o dello smaltimento. (GU n.255 del 02.11.2001) Collegati
D.P.R. 24 maggio 1988, n. 216Decreto Legislativo 22 maggio 1999 n. 209
Leggi tutto
Mag 31, 2022 119

D.P.R. 24 maggio 1988, n. 216

D.P.R. 24 maggio 1988, n. 216 Attuazione della direttiva CEE n. 85/467 recante sesta modifica (PCB/PCT) della direttiva CEE n. 76/769 concernente il ravvicinamento delle disposizioni legislative, regolamentari ed amministrative degli Stati membri relative alle restrizioni in materia di immissione… Leggi tutto
Mag 30, 2022 154

Regolamento delegato (UE) 2022/825

Regolamento delegato (UE) 2022/825 Regolamento delegato (UE) 2022/825 della Commissione del 17 marzo 2022 che modifica l’allegato II del regolamento delegato (UE) n. 1062/2014 relativo al programma di lavoro per l’esame sistematico di tutti i principi attivi esistenti contenuti nei biocidi di cui… Leggi tutto
Mag 30, 2022 109

Regolamento (CE) n. 907/2006

Regolamento (CE) n. 907/2006 Regolamento (CE) n. 907/2006 della Commissione, del 20 giugno 2006, che modifica il regolamento (CE) n. 648/2004 del Parlamento europeo e del Consiglio relativo ai detergenti ai fini di un adeguamento degli allegati III e VII. (GU L 168, 21.6.2006)… Leggi tutto

Più letti Chemicals

Regolamento  CE  n  178 2002
Mar 17, 2022 64931

Regolamento (CE) N. 178/2002

Regolamento (CE) n. 178/2002 Regolamento (CE) n. 178/2002 del Parlamento europeo e del Consiglio del 28 gennaio 2002 che stabilisce i principi e i requisiti generali della legislazione alimentare, istituisce l'Autorità europea per la sicurezza alimentare e fissa procedure nel campo della sicurezza… Leggi tutto